30 results
Functional Dyspepsia - Pathophysiology, Diagnosis and Management
Risk factors: Non-steroidal anti-inflammatory drugs, Psychological comorbidity, Helicobacter pylori infection,
Diagnosis and Management ... sex, Smoking Symptoms ... : Bothersome symptoms ... a structurally normal ... #algorithm #gastroenterology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
Constitutional symptoms ... CRP - Usually normal ... constitutional symptoms ... • Treatment: ... #sle #comparison
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Disease, PRES Pathophysiology ... Puncture, EEG Treatment ... Erythematosus #SLE #CNS #neurology ... cerebritis #diagnosis #management ... #treatment
Treatment Algorithm for Active Proliferative Lupus Nephritis (Class III/IV or Mixed Class III/IV + V)
Induction Therapy
Treatment Algorithm ... Proliferative Lupus ... Protective Measures #Treatment ... #Nephritis #management ... #nephrology
Helicobacter Pylori (H. pylori) Infection - Diagnosis and Management - GrepMed Handbook
Presentation: Dyspepsia / Peptic Ulcer
Diagnosis and Management ... or oral-oral) ... past infection Management ... #Treatment #quadruple ... quadrupletherapy #gastroenterology
Statin Induced Muscle Toxicity - Summary

Clinical Presentation:
 • Elevations of serum creatine kinase with proximal myalgia
any time during treatment ... GBS), systemic lupus ... Stop statin • Oral ... myopathy #diagnosis #management ... #treatment
Intracranial Hemorrhage (ICH) and Increased Intracranial Pressure (ICP) - Pathophysiology
ICH Management:
1. Manage Blood Pressure
  •
ICH Management ... lidocaine, +/- pre-treatment ... Maintain Normals ... #neurology #neurosurgery ... #management
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
Multiple Sclerosis Treatment ... objective evidence of neurologic ... mg) without an oral ... sclerosis #diagnosis #management ... #neurology #treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Pathophysiology ... Diagnosis: >3 symptoms ... 500 mg QD until normal ... APML #diagnosis #management
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Pathophysiology ... CSF PROTEIN - NORMAL ... Treatment: • Plasmapheresis ... Syndrome #diagnosis #management ... #treatment #neurology